The government's new "Open Payments" website is intended to let you find out whether your doctor is getting freebies, travel or other financial benefits from drug companies and medical device manufacturers. But it doesn't ...
Oct 2, 2014
0
0
Confusion over a 1997 Food and Drug Administration (FDA) rule that eases the way for food manufacturers to use ingredients "generally regarded as safe," or GRAS, has inspired a new initiative by food makers. Food safety advocates ...
Sep 24, 2014
0
0
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...
Aug 19, 2014
0
0
A new inhaled medication has the potential to treat mild asthma and allergies by interrupting the production of an immune system protein that triggers allergic reactions, a new study reports.
Jul 2, 2014
0
0
The European Medicines Agency (EMA) receives comprehensive clinical study data from drug manufacturers. These data form the basis for the decision on the approval of new drugs. To make this information available to researchers ...
May 27, 2014
0
0
America's large food companies are trying to head off efforts to enact mandatory labeling of genetically modified ingredients by proposing new voluntary labels nationwide.
Feb 6, 2014
0
0
Shares in one of India's biggest drugmakers, Ranbaxy Laboratories, slid 19 percent Friday after the US Food and Drug Administration suspended imports from a fourth manufacturing plant of the firm.
Jan 24, 2014
0
0
The Food and Drug Administration will delay sweeping food safety rules proposed earlier this year and revise them to better accommodate farmers and businesses who would be affected.
Dec 19, 2013
0
0
India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.
Sep 21, 2013
0
0
Shares in Indian generic drugs giant Ranbaxy Laboratories crashed by as much as 35 percent on Monday after the US Food and Drug Administration suspended imports from one of its factories.
Sep 16, 2013
0
0
